Skip to content

BIS-Guided Sedation Monitoring

BIS-Guided Sedation Monitoring: A Prospective Randomized Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02045927
Enrollment
19
Registered
2014-01-27
Start date
2014-01-31
Completion date
2015-12-31
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Who Are Mechanically Ventilated and Sedated

Keywords

sedation, BIS, monitoring

Brief summary

This study looks to assess whether monitoring sedation status in mechanically-ventilated Medical Surgical Intensive Care Unit (MSICU) patients using Bispectral index (BIS) monitor-augmented sedation monitoring as opposed to Richmond Agitation Sedation Scale (RASS) score is associated with decreased duration of mechanical ventilation. Investigators hypothesize that using BIS monitors to help monitor depth of sedation in mechanically ventilated ICU patient will result in a decreased duration of mechanical ventilation when compared to solely utilizing clinical sedation scales such as RASS.

Detailed description

Participants will be randomized into two groups, the intervention group will receive sedation monitoring with BIS monitoring plus RASS. The control group will receive sedation monitoring with RASS score only. Randomization will be accomplished through online randomization software. For randomization purposes, the intervention group will be labeled as the A group. The control group will labeled as the B group. In the BIS-augmented group, sedation requirement will be titrated according to an average of BIS reading in the 5 minute period prior to assessment with a goal of maintaining a value of (60-70) in addition to a RASS score goal of (-1 to -2), provided no noxious stimulation such as endotracheal suctioning and/or wound dressing has occurred for at least 30 minutes, BIS values have been stable for at least 5 minutes, signal quality index (\>80%), minimal EMG interference (\<50%), patient is not shivering, and patient does not have warmer or other devices that may produce an electric current on their body or nearby. In the RASS group, sedation requirements will be titrated to maintain a RASS score of (-1 to -2), will be assessed via the nurse taking care of the patient provided no noxious stimulation has occurred for at least 30 minutes prior to assessment. Both groups will have sedation assessment at least every 6 hours during a 12 hour shift and as needed as per ICU RN and/or physician. Nurses will be free to exercise their judgment if they deem that their patients require more or less sedation that is inconsistent with patient's BIS or RASS score, they will, however, be required to provide a rationale for their judgment and record such events on a special form created for this study.

Interventions

OTHERsedation monitoring with RASS score
OTHERsedation monitoring with BIS-Guided monitoring

Sponsors

Englewood Hospital and Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \>18 years of age. * Patients expected to be mechanically ventilated and sedated with continuous intravenous infusions of Propofol or Midazolam and fentanyl for \>= 24 hours within 12 hours of screening.

Exclusion criteria

* Patients with Seizure disorders acute neurological injury, severe dementia or anoxic brain injury. * Patients with tracheostomies. * Patients requiring neuromuscular blocking agents (NMBA). * Patients transferred from another ICU while mechanically ventilated. * Patients with cardiac pacemakers. * Peri-cardiac arrest patients. * Patients with induced hypothermia. * Pregnant patients. * Patients with no known Legally Authorized Representative (LAR).

Design outcomes

Primary

MeasureTime frame
duration of mechanical ventilationfrom enrollment to extubation, an expected average of 4 days

Secondary

MeasureTime frameDescription
total sedation medication dosefrom enrollment until extubation, an expected average of 4 days
undersedationfrom enrollment to extubation, an expected average of 4 daysmeasured by self-initiated medical support device removal, time in hours spent in physical restraints, or ventilator asynchrony

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026